Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Emerald Health Therapeutics Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by TITOOOon Mar 09, 2017 10:15pm
98 Views
Post# 25961278

RE:RE:Pesticide scandal now. Great.

RE:RE:Pesticide scandal now. Great.

Mtherfckers - selling pesticides marijuana to sick people!

According to minutes from a Canadian Medical Cannabis Industry Association (CMCIA) conference call held in February that year, two federally licensed medical marijuana growers, Tilray and MedReleaf, were in favor of seeking federal approval for the right to use myclobutanil and were seeking broader industry support for the idea. A third company, Thunderbird Medical, now known as Emerald Health, wanted permission to use the chemicals AzaMax and Spinosad, which were prohibited under federal rules.
 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities